Pseudovirus mimics cell entry and trafficking of the human polyomavirus JCPyV

Virus Research

Volumn 178, Issue 2, 2013, Pages 281-286

  Gee, Gretchen V ^a   O'Hara, Bethany A ^a   Derdowski, Aaron ^a   Atwood, Walter J ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

JC polyomavirus; Natalizumab; Progressive multifocal leukoencephalopathy; Pseudovirus; Virus entry

Indexed keywords

ANTIVIRUS AGENT;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DRUG SCREENING; EMBRYO; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; HUMAN POLYOMAVIRUS JCPYV; POLYOMA VIRUS; PRIORITY JOURNAL; VIROGENESIS; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS GENOME; VIRUS REPLICATION;

JC POLYOMAVIRUS; POLYOMAVIRUS;

JC POLYOMAVIRUS; NATALIZUMAB; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PSEUDOVIRUS; VIRUS ENTRY;

ANTIVIRAL AGENTS; CELL LINE; DRUG EVALUATION, PRECLINICAL; HUMANS; JC VIRUS; VIROLOGY; VIRUS INTERNALIZATION;

EID: 84888199955     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2013.09.030     Document Type: Article

References (39)

1. Ashok A., Atwood W.J. Contrasting roles of endosomal pH and the cytoskeleton in infection of human glial cells by JC virus and simian virus 40. J. Virol. 2003, 77(2):1347-1356.
2. Baldwin K.J., Hogg J.P. Progressive multifocal leukoencephalopathy in patients with multiple sclerosis. Curr. Opin. Neurol. 2013, 26(3):318-323.
3. Baum S., Ashok A., Gee G., Dimitrova S., Querbes W., Jordan J., Atwood W.J. Early events in the life cycle of JC virus as potential therapeutic targets for the treatment of progressive multifocal leukoencephalopathy. J. Neurovirol. 2003, 9(Suppl. 1):32-37.
4. Buck C.B., Pastrana D.V., Lowy D.R., Schiller J.T. Generation of HPV pseudovirions using transfection and their use in neutralization assays. Methods Mol. Med. 2005, 119:445-462.
5. Chen B.J., Atwood W.J. Construction of a novel JCV/SV40 hybrid virus (JCSV) reveals a role for the JCV capsid in viral tropism. Virology 2002, 300(2):282-290.
6. Daniel A.M., Swenson J.J., Mayreddy R.P., Khalili K., Frisque R.J. Sequences within the early and late promoters of archetype JC virus restrict viral DNA replication and infectivity. Virology 1996, 216(1):90-101.
7. Eash S., Atwood W.J. Involvement of cytoskeletal components in BK virus infectious entry. J. Virol. 2005, 79(18):11734-11741.
8. Elphick G.F., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., Dugan A., Stanifer M., Bhatnagar A., Kroeze W.K., Roth B.L., Atwood W.J. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004, 306(5700):1380-1383.
9. Engsig F.N., Hansen A.B., Omland L.H., Kronborg G., Gerstoft J., Laursen A.L., Pedersen C., Mogensen C.B., Nielsen L., Obel N. Incidence, clinical presentation, and outcome of progressive multifocal leukoencephalopathy in HIV-infected patients during the highly active antiretroviral therapy era: a nationwide cohort study. J. Infect. Dis. 2009, 199(1):77-83.
10. Fang C.Y., Lin P.Y., Ou W.C., Chen P.L., Shen C.H., Chang D., Wang M. Analysis of the size of DNA packaged by the human JC virus-like particle. J. Virol. Methods 2012, 182(1-2):87-92.
11. FDA Public Health Advisory: Life-threatening Brain Infection in Patients with Systemic Lupus Erythematosus After Rituxan (Rituximab) Treatment 2006, U.S. Food and Drug Administration.
12. FDA Myfortic (mycophenolic acid) delayed-release tablet. Detailed View Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research 2010, U.S. Food and Drug Administration.
13. FDA FDA permits marketing of first test for risk of rare brain infection in some people treated with Tysabri 2012, U.S. Food and Drug Administration.
14. Ferenczy M.W., Marshall L.J., Nelson C.D., Atwood W.J., Nath A., Khalili K., Major E.O. Molecular biology, epidemiology, and pathogenesis of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain. Clin. Microbiol. Rev. 2012, 25(3):471-506.
15. Gardner S.D., Field A.M., Coleman D.V., Hulme B. New human papovavirus (B.K.) isolated from urine after renal transplantation. Lancet 1971, 1(7712):1253-1257.
16. Gee G.V., Manley K., Atwood W.J. Derivation of a JC virus-resistant human glial cell line: implications for the identification of host cell factors that determine viral tropism. Virology 2003, 314(1):101-109.
17. Hara K., Sugimoto C., Kitamura T., Aoki N., Taguchi F., Yogo Y. Archetype JC virus efficiently replicates in COS-7 cells, simian cells constitutively expressing simian virus 40T antigen. J. Virol. 1998, 72(7):5335-5342.
18. Jensen P.N., Major E.O. A classification scheme for human polyomavirus JCV variants based on the nucleotide sequence of the noncoding regulatory region. J. Neurovirol. 2001, 7(4):280-287.
19. Jiang M., Abend J.R., Tsai B., Imperiale M.J. Early events during BK virus entry and disassembly. J. Virol. 2009, 83(3):1350-1358.
20. Kenney S., Natarajan V., Strike D., Khoury G., Salzman N.P. JC virus enhancer-promoter active in human brain cells. Science 1984, 226(4680):1337-1339.
21. Kim H.S., Goncalves N.M., Henson J.W. Glial cell-specific regulation of the JC virus early promoter by large T antigen. J. Virol. 2000, 74(2):755-763.
22. Liebl D., Difato F., Hornikova L., Mannova P., Stokrova J., Forstova J. Mouse polyomavirus enters early endosomes, requires their acidic pH for productive infection, and meets transferrin cargo in Rab11-positive endosomes. J. Virol. 2006, 80(9):4610-4622.
23. Liu C.K., Atwood W.J. SV40 Protocols. Methods in Molecular Biology 2001, vol. 165. Humana Press, Totowa, NJ.
24. Liu C.K., Wei G., Atwood W.J. Infection of glial cells by the human polyomavirus JC is mediated by an N-linked glycoprotein containing terminal alpha(2-6)-linked sialic acids. J. Virol. 1998, 72(6):4643-4649.
25. Mahon C., Liang B., Tikhanovich I., Abend J.R., Imperiale M.J., Nasheuer H.P., Folk W.R. Restriction of human polyomavirus BK virus DNA replication in murine cells and extracts. J. Virol. 2009, 83(11):5708-5717.
26. Major E.O., Miller A.E., Mourrain P., Traub R.G., de Widt E., Sever J. Establishment of a line of human fetal glial cells that supports JC virus multiplication. Proc. Natl. Acad. Sci. U. S. A. 1985, 82(4):1257-1261.
27. Mandl C., Walker D.L., Frisque R.J. Derivation and characterization of POJ cells, transformed human fetal glial cells that retain their permissivity for JC virus. J. Virol. 1987, 61(3):755-763.
28. Nelson C.D., Derdowski A., Maginnis M.S., O'Hara B.A., Atwood W.J. The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry. Virology 2012, 428(1):30-40.
29. Ohkuma S., Poole B. Fluorescence probe measurement of the intralysosomal pH in living cells and the perturbation of pH by various agents. Proc. Natl. Acad. Sci. U. S. A. 1978, 75(7):3327-3331.
30. Pastrana D.V., Tolstov Y.L., Becker J.C., Moore P.S., Chang Y., Buck C.B. Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog. 2009, 5(9):e1000578.
31. Pho M.T., Ashok A., Atwood W.J. JC virus enters human glial cells by clathrin-dependent receptor-mediated endocytosis. J. Virol. 2000, 74(5):2288-2292.
32. Pietropaolo V., Degener A.M., Di Taranto C., Sinibaldi L., Orsi N. The in vitro effect of monensin on BK polyomavirus replication. New Microbiol. 1995, 18(4):341-349.
33. Pleasure S.J., Lee V.M. NTera 2 cells: a human cell line which displays characteristics expected of a human committed neuronal progenitor cell. J. Neurosci. Res. 1993, 35(6):585-602.
34. Schmedt N., Andersohn F., Garbe E. Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports within the US Adverse Event Reporting System (AERS). Pharmacoepidemiol. Drug Safety 2012, 21(11):1216-1220.
35. Shmigol A., Kostyuk P., Verkhratsky A. Dual action of thapsigargin on calcium mobilization in sensory neurons: inhibition of Ca2+ uptake by caffeine-sensitive pools and blockade of plasmalemmal Ca2+ channels. Neuroscience 1995, 65(4):1109-1118.
36. Simon M.A., Ilyinskii P.O., Baskin G.B., Knight H.Y., Pauley D.R., Lackner A.A. Association of simian virus 40 with a central nervous system lesion distinct from progressive multifocal leukoencephalopathy in macaques with AIDS. Am. J. Pathol. 1999, 154(2):437-446.
37. Steiner I., Berger J.R. Update on progressive multifocal leukoencephalopathy. Curr. Neurol. Neurosci. Rep. 2012, 12(6):680-686.
38. Tolstov Y.L., Pastrana D.V., Feng H., Becker J.C., Jenkins F.J., Moschos S., Chang Y., Buck C.B., Moore P.S. Human Merkel cell polyomavirus infection II. MCV is a common human infection that can be detected by conformational capsid epitope immunoassays. Int. J. Cancer 2009, 125(6):1250-1256.
39. van Rossum J.A., Vennegoor A., Balk L., Uitdehaag B.M., Polman C.H., Killestein J. Safety, anxiety and natalizumab continuation in JC virus-seropositive MS patients. Mult. Scler. 2013, July 4.